Product Information
ARAZLO 0.045% LOTION is a brand product labeled by Bausch Health US LLC, priced at $11.4529 per GM under NDC 00187209845. Its NADAC has been published 203 times since Nov 17, 2021.
FDA first approved this application on Dec 18, 2019.
The High Outlier badge above means this manufacturer's average price in the tazarotene market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.45 mg/g
Manufacturer
Bausch Health US LLCNDC
00187209845
Classification
Brand
Dosage Form
LOTION
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
TAZAROTENEApproval Type
New Drug (NDA)
FDA Application
NDA211882FDA Approved
12/18/2019
On Market Since
12/19/2019
Pharmacological Classes
Price Statistics
The NADAC for ARAZLO 0.045% LOTION has been published 203 times since Nov 17, 2021, and over the history we have for it it has risen 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4529 per GM |
|---|---|
| All-time high | $11.4902 (Jul 16, 2025) |
| All-time low | $9.5167 (Nov 17, 2021) |
| Median price | $10.9855 |
| Average price | $10.8894 |
| Largest weekly change | +8.9% (Jan 11, 2023) |
| Weeks tracked | 203 |
| Tracking since | Nov 17, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+4.3%
5Y
N/A
All
+20.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tazarotene market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tazarotene market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARAZLO 0.045% LOTION?
The current National Average Drug Acquisition Cost (NADAC) for ARAZLO 0.045% LOTION, manufactured by Bausch Health US LLC, is $11.4529 per GM (NDC 00187209845), effective Oct 1, 2025.
How has the price of ARAZLO 0.045% LOTION changed over time?
Over the history we have for it, the NADAC for ARAZLO 0.045% LOTION has risen 20.3%. It has been tracked across 203 weekly CMS publications since Nov 17, 2021.
What are the highest and lowest recorded NADAC prices for ARAZLO 0.045% LOTION?
Since Nov 17, 2021, the NADAC for ARAZLO 0.045% LOTION has ranged from a low of $9.5167 (Nov 17, 2021) to a high of $11.4902 (Jul 16, 2025), with a median of $10.9855 per GM.
Are there cheaper alternatives to ARAZLO 0.045% LOTION?
No other NADAC-published product currently shares the active ingredient and strength of ARAZLO 0.045% LOTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ARAZLO 0.045% LOTION?
ARAZLO 0.045% LOTION (NDC 00187209845) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.